Table: Prism Biolab - Q1 parent results
Feb 14 (Reuters)-
Prism Biolab Co., Ltd.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Dec 31, 2024 Dec 31, 2023 Sep 30, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 125 mln
Operating loss 236 mln
Recurring loss 180 mln
Net loss 191 mln
EPS loss 5.30 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Prism Biolab Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=206A.T